Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype

Clinical Chemistry

Volumn 49, Issue 2, 2003, Pages 295-302

  Moat, Stuart J ^a   Ashfield Watt, Pauline A L ^a   Powers, Hilary J ^b   Newcombe, Robert G ^a   McDowell, Ian F W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; PLACEBO; RIBOFLAVIN;

ADULT; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; CATALYSIS; CATALYST; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; ENZYME ACTIVATION; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; MALE; NORMAL HUMAN; RIBOFLAVIN DEFICIENCY;

ADOLESCENT; ADULT; AGED; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; FEMALE; FOLIC ACID; GENOTYPE; GLUTATHIONE REDUCTASE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; REGRESSION ANALYSIS; RIBOFLAVIN;

EID: 0037305374     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.2.295     Document Type: Article

References (24)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
2. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998;5:229-32.
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, et al. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
4. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a metaanalysis. Circulation 1998;98:2520-6.
5. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ 1998;316:894-8.
6. Bates CJ, Fuller NJ. The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat. Br J Nutr 1986;55:455-64.
7. Lakshmi R, Lakshmi AV, Bamji MS. Mechanism of impaired skin collagen maturity in riboflavin or pyridoxine deficiency. J Biosci 1990;15:289-95.
8. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000;46:1065-71.
9. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate amelio-rates human hyperhomocysteinemia. Nat Struct Biol 1999;6:359-65.
10. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 2001;98:14853-8.
11. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613-21.
12. Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PW, et al. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 2002;132:283-8.
13. Pullin CH, Ashfield-Watt PAL, Burr ML, Clark ZE, Lewis MJ, Moat SJ, et al. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 2001;38:1799-805.
14. Ashfield-Watt PA, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, et al. Methylenetetrahydrofolate reductase (C677T) genotype modulates blood folate and homocysteine responses to a folate rich diet or a low dose folic acid supplementation: a randomised controlled trial. Am J Clin Nutr 2002;76:180-6.
15. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. McCance and Widdowson's the composition of foods [Database]. Cambridge, UK: Royal Society of Chemistry, 1991.
16. Crawley H. Food portion sizes. London: MAFF/HMSO, 1998.
17. Clark ZE, Bowen DJ, Whatley SD, Bellamy MF, Collins PW, McDowell IF. Genotyping method for methylenetetrahydrofolate reductase (C677T thermolabile variant) using heteroduplex technology. Clin Chem 1998;44:2360-2.
18. Ashfield-Watt PAL, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, Burr ML, et al. A comparison of the effect of '5-a-day' fruits and vegetables advice or folic fortified foods on plasma folate and homocysteine. Eur J Clin Nutr 2002;in press.
19. Capo-chichi CD, Gueant JL, Feillet F, Namour F, Vidailhet M. Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2000;739:219-24.
20. Powers HJ, Bates CJ, Duerden JM. Effects of riboflavin deficiency in rats on some aspects of iron metabolism. Int J Vitam Nutr Res 1983;53:371-6.
21. Powers HJ. Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc 1999;58:435-40.
22. Gregory J, Lowes S, Bates CJ, Prentice A, Jackson LV. National Diet and Nutrition Survey of young people aged 4 to 18 years. Vol. 1: Report of the Diet and Nutrition Survey [Database]. London: The Stationary Office, 2000.
23. Gregory J, Foster K, Tyler H, Wiseman M. The Dietary and Nutritional Survey of British adults. Office of Population and Consensus Surveys. London: HMSO, 1990.
24. Finch S, Doyle W, Lowe C, Bates CJ, Prentice A, Smithers G, et al. National Diet and Nutrition Survey. People aged 65 years and over. London: HMSO, 2000.